Kathrin Giehl, M.Sc.

Kathrin Giehl’s primary research focus is to advance the understanding of underlying neural mechanisms involved in Parkinson’s and Huntington’s disease. Concerning Parkinson’s disease, she is particularly interested in elucidating mechanism responsible for distinct cognitive impairments, which are frequently observed in this patient cohort, and to investigate the effects of cognitive training on a neural level in order to ameliorate these difficulties. Moreover, she is interested in better understanding the role of tau in the clinical presentation and progression of Huntington’s disease. For her research, she utilizes behavioral paradigms and various neuroimaging methods, such as functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET).

Selected publications:

Tahmasian M, Eickhoff SB, Giehl K, Schwartz F, Herz DM, Drzezga A, et al. Resting-state functional reorganization in Parkinson’s disease: An activation likelihood estimation meta-analysis. Cortex. 2017 Jul; 92:119–38

Zokaei N, Giehl K, Sillence A, Neville MJ, Karpe F, Nobre AC, Husain M. Sex and APOE: A memory advantage in male APOE ε4 carriers in midlife. Cortex. 2017 Mar 31; 88:98-105

Chong TT, Apps M, Giehl K, Sillence A, Grima LL, Husain M. Neurocomputational mechanisms    underlying subjective valuation of effort costs. PLoS biology. 2017 Feb 24;15(2): e1002598

Hammes J, Bischof GN, Giehl K, Faber J, Drzezga A, Klockgether T, et al. Elevated in vivo [18F]-AV-1451 uptake in a patient with progressive supranuclear palsy. Mov. Disord. 2017 Jan;32(1):170–1

Rolinski M, Zokaei N, Baig F, Giehl K, Quinnell T, Zaiwalla Z, Mackay CE, Husain M, Hu MTM. Visual short-term memory deficits in REM sleep behaviour disorder mirror those in Parkinson’s disease. Brain. 2015 Nov 18; 139(1): 47-53.

Curriculum Vitae  (download CV as pdf)

Contact:

Kathrin Giehl, M.Sc.
PhD student

Gérard Bischof receives Travel Grant

Dr. Gérard N. Bischof receives a travel grant to present his work on the relationship between CSF markers of p-tau and t-tau to in vivo tau deposition as measured by PET in typical and atypical Alzheimer’s disease at the annual meeting of the Society for Nuclear Medicine and Molecular Imaging (SNMMI) in Denver, USA.

Read the abstract here.

1st Cologne Neuroscience Day

The MMNI group is excited to participate in the very first Cologne Neuroscience Day (CNS) as a platform for young neuroscientists in Cologne to present their work. Talks will be given by Dr. Gérard N. Bischof and Dr. Jochen Hammes.

Read the full program here.